SF3306
Prior authorization on medications prescribed for antineoplastic cancer treatment prohibition; prior authorization denials based on timing of the provided health care service prohibition; expedited prior authorization review for prescriptions that have previously been authorized or covered requirement
Legislative Session 94 (2025-2026)
AI Generated Summary
Purpose of the Bill
The bill aims to streamline and simplify the prior authorization process for specific health services and medications under health insurance plans in Minnesota. It specifically addresses requirements related to antineoplastic cancer treatments, expediting prior authorization for ongoing prescriptions, and implementing technological solutions to improve the process.
Main Provisions
Prohibition of Prior Authorization for Certain Treatments: The bill prohibits prior authorization for emergency services, outpatient mental health and substance use disorder treatments, and pediatric hospice care, among others. For antineoplastic cancer treatments specifically, prior authorization is prohibited if the treatment aligns with the National Comprehensive Cancer Network guidelines.
Expedited Process for Previously Authorized Medications: The bill requires expedited review for medications that have been previously authorized or covered for a patient, ensuring that any continued medication is reviewed promptly.
Technological Integration: By January 1, 2027, health plans and utilization review organizations must have an application programming interface (API) to automate the prior authorization process for non-drug services, using specific interoperability standards.
Significant Changes to Existing Law
Prior Authorization Submission Requirements: Providers must be able to submit prior authorization requests through various channels (phone, fax, voicemail, electronic) 24/7. Only non-dental services are impacted by this change.
Automated Systems Requirement: The bill mandates automated systems (API) to process prior authorization requests for health services, enhancing efficiency in handling such requests and ensuring quick determination and communication with healthcare providers.
Protection Against Timing-Based Denials: Utilization review organizations cannot deny a prior authorization request or appeal based on the timing of the submission if it is within seven days after the service.
Relevant Terms
- Prior Authorization
- Antineoplastic Cancer Treatment
- National Comprehensive Cancer Network (NCCN)
- Utilization Review
- Health Insurance
- Interoperability
- Application Programming Interface (API)
Actions
| Date | Chamber | Where | Type | Name | Committee Name |
|---|---|---|---|---|---|
| April 07, 2025 | Senate | Action | Introduction and first reading | ||
| April 07, 2025 | Senate | Action | Referred to | Commerce and Consumer Protection | |
| April 10, 2025 | Senate | Action | Author added | ||
| Showing the 5 most recent stages. This bill has 3 stages in total. Log in to view all stages | |||||
Citations
You must be logged in to view citations.
Progress through the legislative process
Sponsors
You must be logged in to view sponsors.